Literature DB >> 22119928

Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice.

Takeshi Miyata1, Tetsuya Harakuni, Toki Taira, Goro Matsuzaki, Takeshi Arakawa.   

Abstract

Methylotrophic yeast (Pichia pastoris) secreted cholera toxin B subunit (CTB) predominantly as a biologically active pentamer (PpCTB) with identical ganglioside binding affinity profiles to that of choleragenoid. Unlike choleragenoid, however, the PpCTB did not induce a footpad edema response in mice. Of the two potential glycosylation sites (NIT(4-6) and NKT(90-92)) for this protein, a N-linked oligosaccharide was identified at Asn4. The oligosaccharide, presumed to extend from the lateral circumference of the CTB pentamer ring structure, was exploited as a site-specific anchoring scaffold for the C-terminal 19-kDa merozoite surface protein-1 (MSP1-19) of the rodent malaria parasite, Plasmodium yoelii. Conjugation of MSP1-19 to PpCTB via its oligosaccharide moiety induced higher protective efficacy against lethal parasite infection than conjugation directly to the PpCTB protein body in both intranasal and subcutaneous immunization regimes. Such increased protection was potentially due to the higher antigen loading capacity of CTB achieved when the antigen was linked to the extended branches of the oligosaccharide. This might have allowed the antigen to reside in more spacious molecular environment with less steric hindrance between the constituent molecules of the fusion complex.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119928     DOI: 10.1016/j.vaccine.2011.11.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Expression of Neospora caninum NcSRS2 surface protein in Pichia pastoris and its application for serodiagnosis of Neospora infection.

Authors:  Amanda Fernandes Pinheiro; Sibele Borsuk; Maria Elisabeth Aires Berne; Luciano da Silva Pinto; Renato Andreotti; Talita Roos; Barbara Couto Rollof; Fábio Pereira Leivas Leite
Journal:  Pathog Glob Health       Date:  2013-04       Impact factor: 2.894

2.  The Corn Smut ('Huitlacoche') as a New Platform for Oral Vaccines.

Authors:  Margarita Juárez-Montiel; Andrea Romero-Maldonado; Elizabeth Monreal-Escalante; Alicia Becerra-Flora; Schuyler S Korban; Sergio Rosales-Mendoza; Juan Francisco Jiménez-Bremont
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 3.  Cholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in Autoimmunity.

Authors:  Thomas Stratmann
Journal:  Vaccines (Basel)       Date:  2015-07-24

Review 4.  Cholera toxin B: one subunit with many pharmaceutical applications.

Authors:  Keegan J Baldauf; Joshua M Royal; Krystal Teasley Hamorsky; Nobuyuki Matoba
Journal:  Toxins (Basel)       Date:  2015-03-20       Impact factor: 4.546

5.  Effect of pressure on refolding of recombinant pentameric cholera toxin B.

Authors:  D Rodrigues; L E Farinha-Arcieri; A M Ventura; R M Chura-Chambi; N V Malavasi; L S Lemke; J S Guimarães; P L Ho; L Morganti
Journal:  J Biotechnol       Date:  2014-01-17       Impact factor: 3.307

6.  Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks.

Authors:  Krystal Teasley Hamorsky; J Calvin Kouokam; Lauren J Bennett; Keegan J Baldauf; Hiroyuki Kajiura; Kazuhito Fujiyama; Nobuyuki Matoba
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07

7.  Th1-biased immunoadjuvant effect of the recombinant B subunit of an Escherichia coli heat-labile enterotoxin on an inactivated porcine reproductive and respiratory syndrome virus antigen via intranasal immunization in mice.

Authors:  Fei Su; Lihua Xu; Yin Xue; Junxing Li; Yuan Fu; Bin Yu; Sai Wang; Xiufang Yuan
Journal:  J Vet Med Sci       Date:  2019-09-16       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.